KMT2A and acute myeloid leukemia: Importantly, significant progress is being made in understanding the molecular basis for the initiation and progression of pediatric KMT2A/MLLT3 AML, as well as defining the individual functions of the KMT2A and MLLT3 in normal human hematopoiesis.